|
1
|
Scott DB: Local anesthetics: Mechanisms of
action and clinical use. Br J Anaesthesia. 48:1031–1032. 1976.
View Article : Google Scholar
|
|
2
|
Hansen TG: Ropivacaine: A pharmacological
review. Expert Rev Neurother. 4:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feldman HS and Covino BG: Comparative
motor-blocking effects of bupivacaine and ropivacaine, a new amino
amide local anesthetic, in the rat and dog. Anesth Analg.
67:1047–1052. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Auyong DB, Cantor DA, Green C and Hanson
NA: The effect of fixation technique on continuous interscalene
nerve block catheter success: A randomized, double-blind trial.
Anesth Analg. 124:959–965. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosen MA, Baysinger CL, Shnider SM, Dailey
PA, Norton M, Curtis JD, Collins M and Davis RL: Evaluation of
neurotoxicity after subarachnoid injection of large volumes of
local anesthetic solutions. Anesth Analg. 62:802–808. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vieira PA, Pulai I, Tsao GC, Manikantan P,
Keller B and Connelly NR: Dexamethasone with bupivacaine increases
duration of analgesia in ultrasound-guided interscalene brachial
plexus blockade. Eur J Anaesthesiol. 27:285–288. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Candido KD, Hennes J, Gonzalez S,
Mikat-Stevens M, Pinzur M, Vasic V and Knezevic NN: Buprenorphine
enhances and prolongs the postoperative analgesic effect of
bupivacaine in patients receiving infragluteal sciatic nerve block.
Anesthesiology. 113:1419–1426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jarbo K, Batra YK and Panda NB: Brachial
plexus block with midazolam and bupivacaine improves analgesia. Can
J Anaesth. 52:822–826. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kaur M and Singh PM: Current role of
dexmedetomidine in clinical anesthesia and intensive care. Anesth
Essays Res. 5:128–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aksu R and Bicer C: Addition of
dexmedetomidine to bupivacaine in supraclavicular brachial plexus
block. Clin Invest Med. 40:E111–E116. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma D, Hossain M, Rajakumaraswamy N, Arshad
M, Sanders RD, Franks NP and Maze M: Dexmedetomidine produces its
neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J
Pharmacol. 502:87–97. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perez-Castro R, Patel S, Garavito-Aguilar
ZV, Rosenberg A, Recio-Pinto E, Zhang J, Blanck TJ and Xu F:
Cytotoxicity of local anesthetics in human neuronal cells. Anesth
Analg. 108:997–1007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reiz S, Häggmark S, Johansson G and Nath
S: Cardiotoxicity of ropivacaine-a new amide local anaesthetic
agent. Acta Anaesthesiol Scand. 33:93–98. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen X, Liang H, Li H, Ou W, Wang HB, Liu H
and Li S: In vitro neurotoxicity by ropivacaine is reduced by
silencing Cav3.3 T-type calcium subunits in neonatal rat sensory
neurons. Artif Cells Nanomed Biotechnol. 46:1617–1624.
2018.PubMed/NCBI
|
|
15
|
Sun Z, Liu H, Guo Q, Xu X, Zhong Z and
Wang N: In vivo and in vitro evidence of the neurotoxic effects of
ropivacaine: The role of the Akt signaling pathway. Mol Med Rep.
6:1455–1459. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang AZ, Ficklscherer A, Gülecyüz MF,
Paulus AC, Niethammer TR, Jansson V and Müller PE: Cell toxicity in
fibroblasts, tenocytes, and human mesenchymal stem cells-a
comparison of necrosis and apoptosis-inducing ability in
ropivacaine, bupivacaine, and triamcinolone. Arthroscopy.
33:840–848. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cai XY, Xia Y, Yang SH, Liu XZ, Shao ZW,
Liu YL, Yang W and Xiong LM: Ropivacaine- and bupivacaine-induced
death of rabbit annulus fibrosus cells in vitro: Involvement of the
mitochondrial apoptotic pathway. Osteoarthritis Cartilage.
23:1763–1775. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhir S, Ganapathy S, Lindsay P and Athwal
GS: Case report: Ropivacaine neurotoxicity at clinical doses in
interscalene brachial plexus block. Can J Anaesth. 54:912–916.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Werdehausen R, Fazeli S, Braun S, Hermanns
H, Essmann F, Hollmann MW, Bauer I and Stevens MF: Apoptosis
induction by different local anaesthetics in a neuroblastoma cell
line. Br J Anaesth. 103:711–718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu ZY, Geng J, Li ZQ, Sun YB, Wang SL,
Masters J, Wang DX, Guo XY, Li M and Ma D: Dexmedetomidine enhances
ropivacaine-induced sciatic nerve injury in diabetic rats. Br J
Anaesth. 122:141–149. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim BS, Choi JH, Baek SH and Lee DH:
Effects of intraneural injection of dexmedetomidine in combination
with ropivacaine in rat sciatic nerve block. Reg Anesth Pain Med.
43:378–384. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thalhammer JG, Vladimirova M, Bershadsky B
and Strichartz GR: Neurologic evaluation of the rat during sciatic
nerve block with lidocaine. Anesthesiology. 82:1013–1025. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brummett CM, Padda AK, Amodeo FS, Welch KB
and Lydic R: Perineural dexmedetomidine added to ropivacaine causes
a dose-dependent increase in the duration of thermal
antinociception in sciatic nerve block in rat. Anesthesiology.
111:1111–1119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Candido KD, Winnie AP, Ghaleb AH, Fattouh
MW and Franco CD: Buprenorphine added to the local anesthetic for
axillary brachial plexus block prolongs postoperative analgesia.
Reg Anesth Pain Med. 27:162–167. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mccartney CJ, Duggan E and Apatu E: Should
we add clonidine to local anesthetic for peripheral nerve blockade?
A qualitative systematic review of the literature. Reg Anesth Pain
Med. 32:330–338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parrington SJ, O'Donnell D, Chan VW,
Brown-Shreves D, Subramanyam R, Qu M and Brull R: Dexamethasone
added to mepivacaine prolongs the duration of analgesia after
supraclavicular brachial plexus blockade. Reg Anesth Pain Med.
35:422–426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosin DL: Distribution of alpha 2A - and
alpha 2C -adrenergic receptor immunoreactivity in the central
nervous system. Methods Mol Biol. 126:475–505. 2000.PubMed/NCBI
|
|
28
|
Singelyn FJ, Gouverneur JM and Robert A: A
minimum dose of clonidine added to mepivacaine prolongs the
duration of anesthesia and analgesia after axillary brachial plexus
block. Reg Anesth. 83:1046–1050. 1996.
|
|
29
|
Nie Y, Tu W, Shen X, Yu W, Yu Y, Song X,
Wang S, Luo A, Cao M, Wu X and Huang S: Dexmedetomidine added to
sufentanil patient-controlled intravenous analgesia relieves the
postoperative pain after cesarean delivery: A prospective
randomized controlled multicenter study. Sci Rep. 8:99522018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brummett CM, Norat MA, Palmisano JM and
Lydic R: Perineural administration of dexmedetomidine in
combination with bupivacaine enhances sensory and motor blockade in
sciatic nerve block without inducing neurotoxicity in rat.
Anesthesiology. 109:502–511. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang YC, Meng QT, Pan X, Xia ZY and Chen
XD: Dexmedetomidine produced analgesic effect via inhibition of HCN
currents. Eur J Pharmacol. 740:560–564. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eisenach JC, De Kock M and Klimscha W:
Alpha(2)-adrenergic agonists for regional anesthesia. A clinical
review of clonidine (1984–1995). Anesthesiology. 85:655–674. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Williams BA, Hough KA, Tsui BY, Ibinson
JW, Gold MS and Gebhart GF: Neurotoxicity of adjuvants used in
perineural anesthesia and analgesia in comparison with ropivacaine.
Reg Anesth Pain Med. 36:225–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang MH, Zhou XM, Cui JZ, Wang KJ, Feng Y
and Zhang HA: Neuroprotective effects of dexmedetomidine on
traumatic brain injury: Involvement of neuronal apoptosis and HSP70
expression. Mol Med Rep. 17:8079–8086. 2018.PubMed/NCBI
|
|
35
|
Sun Z, Zhao T, Lv S, Gao Y, Masters J and
Hao W: Dexmedetomidine attenuates spinal cord ischemia-reperfusion
injury through both anti-inflammation and anti-apoptosis mechanisms
in rabbits. J Transl Med. 16:2092018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wei Y, Hu J, Liang Y, Zhong Y, He D, Qin
Y, Li L, Chen J, Xiao Q and Xie Y: Dexmedetomidine pretreatment
attenuates propofol-induced neurotoxicity in neuronal cultures from
the rat hippocampus. Mol Med Rep. 14:3413–3420. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li J, Xiong M, Nadavaluru PR, Zuo W, Ye
JH, Eloy JD and Bekker A: Dexmedetomidine attenuates neurotoxicity
induced by prenatal propofol exposure. J Neurosurg Anesthesiol.
28:51–64. 2015. View Article : Google Scholar
|
